Crossref
Managing Adverse Effects of GLP-1 Agonists: Practical Insights From Dr. Bridget E. Shields
Cutis · 2025
DOI: 10.12788/cutis.1286 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cutis, 2025. Verfasst von Bridget E Shields. Beteiligte Einrichtung: Dr. Shields is from the Department of Dermatology, University of Wisconsin, Madison.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Dr. Shields is from the Department of Dermatology, University of Wisconsin, Madison.
Zitieren
APA
Shields, B. E. (2025). Managing Adverse Effects of GLP-1 Agonists: Practical Insights From Dr. Bridget E. Shields. Cutis. https://doi.org/10.12788/cutis.1286
Vancouver
Shields BE. Managing Adverse Effects of GLP-1 Agonists: Practical Insights From Dr. Bridget E. Shields. Cutis. 2025. doi:10.12788/cutis.1286
BibTeX
@article{Shields2025,
author = {Shields, Bridget E},
title = {Managing Adverse Effects of GLP-1 Agonists: Practical Insights From Dr. Bridget E. Shields},
journal = {Cutis},
year = {2025},
doi = {10.12788/cutis.1286}
}
EUVIMED